Public 990 Summary
EIN 311611837 · Latest tax year 2025 · Usable public filing summary
UNIONDALE, NY · Human Services · lustgarten.org
Donor quick answer
MARC LUSTGARTEN PANCREATIC CANCER has a public Form 990 profile, but an AlignMint donation portal is not live yet. Review the public filing signals and share the claim link with the nonprofit if the profile should be activated.
Program ratio
Not enough public dataFundraising ratio
0.1%Admin ratio
Not enough public dataProgram ratio estimates the share of reported expenses used for programs. Fundraising ratio estimates fundraising expense share. Admin ratio estimates management and general expense share when the public fields reconcile.
Ratios use reported functional expenses when available and are only derived when the public fields reconcile with total expenses.
Recent prepared public snapshots appear here as the directory rollup processes more 990 filings. Use the ProPublica link for the full public filing archive when a prior year is not shown yet.
Revenue: $37,190,710
Expenses: $27,180,092
Program ratio: Not reported
Latest public tax year: 2025. Ask for newer financials if the organization has not filed a recent 990 yet.
Compare the mission narrative with the program-service rows and the nonprofit's current website.
Program ratio: Not enough public data. Fundraising ratio: 0.1%. Admin ratio: Not enough public data.
This profile is public research only until the nonprofit claims it and connects payment integrations.
THE LUSTGARTEN FOUNDATION IS THE LARGEST PRIVATE FUNDER OF PANCREATIC CANCER RESEARCH IN THE WORLD. SEE SCHEDULE O.THE LUSTGARTEN FOUNDATION IS BOLDLY LEADING THE WAY THROUGH HOPE AND INNOVATION, TURNING FEAR INTO ACTION THROUGH EDUCATION AND EMPOWERMENT, AND ADVANCING THE BEST SCIENCE TO TRANSFORM PANCREATIC CANCER INTO A CURABLE DISEASE. THE FOUNDATION FOCUSES ON TRANSLATING OUR UNDERSTANDING OF THE UNDERLYING BIOLOGY OF PANCREATIC CANCER INTO CLINICAL APPLICATIONS TO CHANGE, EXTEND, AND ULTIMATELY SAVE PATIENTS' LIVES. IN FY25, THE FOUNDATION AWARDED $18 MILLION TO FUEL CUTTING-EDGE PANCREATIC CANCER RESEARCH, INCLUDING 10 NEW GRANTS TO RESEARCHERS AT SEVEN LEADING INSTITUTIONS. RESEARCH EFFORTS ARE CONCENTRATED ON THREE KEY PILLARS: EARLY DETECTION AND INTERCEPTION, DRUG DEVELOPMENT, AND PERSONALIZED MEDICINE.
Public Form 990 officer rows; not a staff or contact directory.
CHAIRMAN
2 hours/week · Reportable compensation: $0
CHAIRMAN EMERITUS
2 hours/week · Reportable compensation: $0
SECRETARY
2 hours/week · Reportable compensation: $0
TREASURER
2 hours/week · Reportable compensation: $0
VICE CHAIRMAN
2 hours/week · Reportable compensation: $0
DIRECTOR
2 hours/week · Reportable compensation: $0
Tax year 2025 · Source 202630559349301013 · Parser opportunity-intelligence-financials-v1
This page is educational and based on public or submitted information. It is not legal, tax, accounting, or financial advice.
Claim the profile with a free AlignMint account. If your organization already has a live AlignMint giving page, this directory can point donors to it after the profile is linked.
